Dr. Anil Nair is the director of the Alzheimer Disease Center in Quincy, Massachusetts. At the center, he directs several clinical research studies as the principal investigator. He is board certified with specialized fellowship training in dementia from the Mayo Clinic. He completed neurology residency at the Cleveland Clinic. His interest area is early and preclinical detection, prevention and treatment of Alzheimer's disease and other neurocognitive disorders and dementias. He also is involved in studies for cognitive impairment in multiple sclerosis and other neurological diseases. He was one of the earliest to use amyloid PET imaging for diagnosis and treatment of dementia and other neurological diseases.
Dr. Anil's teaching responsibilities at Boston University include lectures in the neuroscience programs for medical students and graduate students. He is an internationally recognized expert on early and preclinical detection, prevention and treatment of Alzheimer's disease. He is the co-editor of the textbook "Geriatric Neurology," a clinically-oriented book designed for clinicians, scientists, and other health professionals involved in the diagnosis, management, and investigation of disease states causing dementia. He also serves on the executive committee of Massachusetts Neurological Association. He was nationally recognized by the American Academy of Neurology by the Palatucci leadership award. At the Alz center, he provides preventive, diagnostic and therapeutic services to patients with dementia, neurodegenerative and related diseases. Dr. Nair is dedicated to providing health care and consultation services of the highest quality and is committed to building partnerships that increase the independence and quality of life of patients with dementia.